1. A. In this chapter, the following terms have the meanings indicated.

2. B. Terms Defined.

   1. (1) “Board” means the Maryland Board of Pharmacy.
   2. (2) “Maryland Medical Assistance Program” means the program of comprehensive medical and other health-related care for indigent and medically indigent individuals.
   3. (3) “Medication therapy management” services are defined as face-to-face consultations that are structured to reduce the risk of adverse events and ensure optimum therapeutic outcomes for targeted patients through improved medication use with disease-state specific education, counseling, and medication review related to treatments, including drug therapy, laboratory tests, or medical devices provided by licensed and practicing pharmacists.
   4. (4) “Participant” means an individual who is certified as eligible for, and is receiving, Medical Assistance benefits.
   5. (5) “Pharmacist” means an individual licensed in good standing to practice pharmacy in the state where the service is provided.
   6. (6) “Program” means the Maryland Medical Assistance Program.

Authority: Health-General Article, §§2-104(b), 2-105(b), 15-103, and 15-148(c), Annotated Code of Maryland

Effective date: December 31, 2018 (45:26 Md. R. 1242)

Regulation .02B amended effective May 1, 2023 (50:8 Md. R. 337); January 6, 2025 (51:26 Md. R. 1187)

Regulation .03 amended effective January 6, 2025 (51:26 Md. R. 1187)

Regulation .03C, D adopted effective May 1, 2023 (50:8 Md. R. 337)

Regulation .04 amended effective May 1, 2023 (50:8 Md. R. 337); January 6, 2025 (51:26 Md. R. 1187)

Regulation .05 amended effective January 6, 2025 (51:26 Md. R. 1187)

Regulation .06 amended effective June 14, 2021 (48:12 Md. R. 473); May 1, 2023 (50:8 Md. R. 337); January 6, 2025 (51:26 Md. R. 1187)